The research team, led by Hend Samy Ibrahim and Eman Hany Elsebaie of the Department of Public Health and Community Medicine at Cairo University’s Faculty of Medicine, together with Eman Ismail Raslan of the Department of Family Medicine, designed the investigation as a cross-sectional comparative study. Rather than sampling a single group, they deliberately recruited two matched cohorts of older adults: 123 patients living with chronic diseases and 123 healthy controls, all aged 65 or above. This comparative structure allowed the investigators to ask not only whether health literacy and successful aging are connected in general, but whether that connection looks different for people already carrying the burden of long-term illness.

Participants completed two validated instruments that anchor the study’s methodology. The Health Literacy Questionnaire, a widely used multidimensional tool, captures the many faces of health literacy, from the ability to read prescription labels and navigate appointment systems to the confidence to ask questions of clinicians and the social support available for understanding health matters. The Successful Aging Scale, meanwhile, operationalizes a concept that gerontologists have debated for decades: aging well is not simply the absence of disease, but a composite of physical function, psychological resilience, social engagement, and life satisfaction. Measuring both constructs in the same individuals allowed the team to quantify the relationship between them with unusual precision for this population.

The results were striking in their consistency. Older patients with chronic diseases scored significantly lower on both health literacy and successful aging than their healthy counterparts, differences that reached statistical significance at p < 0.001. More importantly, when the researchers examined the relationship across the entire sample, health literacy and successful aging moved together: the correlation coefficient of r = 0.612 indicates a moderately strong positive association, meaning that older adults who scored higher on understanding and using health information also reported markedly better aging outcomes. In epidemiological terms, this is a substantial effect, and it held regardless of whether a participant was in the chronic disease group or the healthy control group.

Correlation alone, however, rarely settles a scientific question, so the team turned to regression analysis to test whether health literacy would remain predictive once other influences were controlled. It did, and emphatically so: health literacy emerged as the strongest independent predictor of successful aging in the regression model. This statistical robustness matters because it suggests the association is not merely a shadow cast by education or wealth. While higher educational attainment and higher income were both associated with better successful aging scores, and while older age, rural residence, and smoking each exerted negative effects, none of these factors displaced health literacy from its position at the top of the predictive hierarchy.

The demographic patterns the study uncovered paint a sobering picture of vulnerability in Egyptian aging. Rural residence emerged as a negative factor, a finding that resonates with longstanding inequities in access to health services, information, and preventive care between urban centers like Cairo and the country’s rural governorates. Smoking, unsurprisingly, was associated with worse aging outcomes, reinforcing decades of evidence about its toll on respiratory and cardiovascular health in later life. The negative effect of advancing age itself underscores the biological reality that successful aging becomes harder to maintain with each passing year, making modifiable factors like health literacy all the more valuable as levers for intervention.

Why might health literacy exert such a powerful influence on how people age? The plausible mechanisms are multiple and mutually reinforcing. Older adults with strong health literacy are better equipped to manage medications correctly, recognize warning symptoms early, and adhere to treatment regimens, all of which can slow the progression of chronic disease. They are more likely to engage in preventive behaviors, from vaccination to screening, that preserve function over time. Beyond the clinical domain, the Health Literacy Questionnaire’s multidimensional design captures social dimensions, including the support people receive from family and community in understanding health matters, which may itself feed into the social engagement and psychological well-being components of successful aging. Health literacy, in this framing, is not merely a cognitive skill but a form of personal and social capital that compounds across the life course.

The Egyptian context gives these findings particular urgency. The country’s population is aging at a pace that outstrips many of its public health preparations, and chronic diseases such as diabetes, hypertension, and cardiovascular conditions impose a growing burden on both families and the health system. Kasr Alainy Hospital, as one of Cairo’s largest and oldest public teaching institutions, serves a patient population that reflects this reality in full: older adults of varying educational backgrounds, incomes, and geographic origins, many managing multiple chronic conditions with limited resources. If health literacy is indeed a modifiable determinant of aging well, then interventions that build it, from clearer medication counseling to community health education programs tailored to older Egyptians, could deliver outsized returns for a health system under strain.

The authors are careful about what their study can and cannot establish. As a cross-sectional design, it captures a single moment in time and cannot prove that higher health literacy causes better aging outcomes; it is equally conceivable that older adults who are aging well find it easier to engage with health information. The team explicitly calls for future research employing longitudinal designs that follow participants over years, community-based probability sampling that extends beyond hospital patients to the broader population, fully validated Arabic versions of the study instruments with psychometric properties reported in the target population, and, ultimately, randomized evaluations of health-literacy interventions to determine whether improving literacy genuinely improves successful-aging outcomes. This candor about limitations is a model of scientific restraint in a field where cross-sectional findings are often oversold.

Even with those caveats, the study’s central message is difficult to ignore. Among older adults in Egypt, the capacity to understand and act on health information travels hand in hand with aging successfully, and it does so more powerfully than income, education, or any other factor the researchers measured. For policymakers, the implication is that investments in health literacy, in plain-language health communication, in patient education, and in the social supports that help older people navigate an increasingly complex medical landscape, may be among the most cost-effective tools available for helping a growing population of seniors not just live longer, but live better. For the rest of the world’s rapidly aging societies, the Cairo findings offer a provocative hypothesis worth testing: the secret to a good old age may begin with something as ordinary as understanding what your doctor just told you.

Subject of Research: The association between health literacy and successful aging among elderly patients in Egypt

Article Title: Health literacy and successful aging among elderly patients at Kasr Alainy Hospital: a cross-sectional comparative study

Article References: Ibrahim, H. S., Raslan, E. I., & Elsebaie, E. H. (2026). Health literacy and successful aging among elderly patients at Kasr Alainy Hospital: a cross-sectional comparative study. BMC Public Health, 26(1), Article 2927. https://doi.org/10.1186/s12889-026-29518-z

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29518-z

Keywords: health literacy, successful aging, elderly patients, gerontology, chronic disease, public health, Egypt, cross-sectional study, Cairo University, healthy aging, geriatric health, health communication

Diabetic kidney disease is the leading cause of chronic kidney failure worldwide, and its burden is expanding in lockstep with the global epidemic of type 2 diabetes. In Egypt, where diabetes prevalence ranks among the highest in the Middle East and North Africa, the clinical stakes are particularly high. Yet the diagnostic toolkit for diabetic nephropathy, the kidney-specific complication of diabetes, has remained stubbornly crude. Physicians typically rely on the urinary albumin-to-creatinine ratio, or UACR, a measure of how much of the protein albumin leaks into the urine, along with estimated glomerular filtration rate, or eGFR, which gauges how well the kidneys filter blood. Both markers have well-known blind spots. Albuminuria can fluctuate with infection, exercise, and glycemic control, and some patients lose filtration capacity without ever spilling significant albumin. The search for a more reliable, earlier, and more specific indicator has therefore become something of a holy grail in nephrology.

Long noncoding RNAs have emerged as unexpected candidates. These molecules, typically longer than two hundred nucleotides, do not code for proteins but instead participate in regulating gene expression, chromatin structure, and cellular signaling. In the kidney, several lncRNAs have been implicated in the fibrotic and inflammatory cascades that progressively scar the delicate filtering units known as glomeruli. PVT1, located on chromosome 8, first attracted attention in cancer biology, where its overexpression drives proliferation in lymphomas and other malignancies. More recently, genetic studies have linked a region near PVT1 to susceptibility to diabetic nephropathy, and experimental work has suggested that the RNA contributes to renal cell injury under high-glucose conditions. What remained uncertain was whether PVT1 levels measurable in the blood track the clinical severity of kidney damage in a real-world patient population.

To answer that question, the Cairo-based team enrolled eighty adults and divided them into four groups of twenty each. Three groups consisted of patients with type 2 diabetes, stratified by their urinary albumin-to-creatinine ratio into those with normal albumin excretion, moderately increased albuminuria, and severely increased albuminuria, the standard staging categories used to grade diabetic kidney disease. The fourth group comprised healthy controls. The researchers also performed fundus examinations to classify the diabetic participants according to whether they had diabetic retinopathy, an eye complication that often parallels kidney involvement. Every participant underwent a full clinical and laboratory workup, and serum levels of PVT1 were quantified using real-time polymerase chain reaction, a technique that amplifies and measures specific RNA sequences with high sensitivity.

The results were striking. Serum PVT1 expression was markedly elevated across the diabetic groups compared with the healthy controls, and within the diabetic cohort, levels climbed with disease stage: patients with severely increased albuminuria showed significantly higher PVT1 than those with normal urinary albumin. In other words, the RNA signal in the blood rose in step with the conventional staging of kidney damage, suggesting that PVT1 is not merely a binary flag for the presence of disease but a graded readout of its progression.

The correlation analysis deepened the picture. PVT1 levels showed a significant positive association with UACR, serum creatinine, age, body mass index, fasting blood glucose, two-hour postprandial glucose, and glycated hemoglobin, or HbA1c. The links to glucose measures are particularly intriguing, because they hint that PVT1 expression responds to the glycemic environment itself, the very insult that drives diabetic tissue damage. The positive association with creatinine, a waste product that accumulates when filtration falters, reinforces the connection to declining renal function. Conversely, PVT1 correlated negatively with eGFR, the best available summary of kidney filtering capacity, as well as with alanine aminotransferase, a liver enzyme, and platelet count. The negative correlations with eGFR and platelets fit a pattern in which advancing kidney disease and its systemic complications are mirrored by falling values of protective or homeostatic markers.

Perhaps the most consequential finding came from the regression analysis. When the researchers tested which variables independently predicted proteinuria, the abnormal leakage of protein into urine that defines progressive diabetic nephropathy, PVT1 stood alone as the sole independent predictor among the diabetic patients. That means that even after accounting for age, glycemic control, and other clinical factors, the serum RNA level carried predictive information about kidney involvement that the other measures did not. If confirmed in larger and more diverse cohorts, this property could make PVT1 a genuinely additive biomarker, one that complements rather than duplicates the existing panel.

The study’s design and context deserve careful attention. It was conducted at Kasr Al-Ainy Hospital, the historic teaching hospital of Cairo University’s Faculty of Medicine, and approved by the institution’s ethical committee with oral and written informed consent obtained from participants or their eligible relatives, in accordance with the Declaration of Helsinki. The cohort size of eighty, while adequate for detecting the reported differences, is modest, and the cross-sectional design captures a single moment in time rather than following patients forward. A cross-sectional correlation between PVT1 and kidney stage cannot by itself prove that the RNA drives disease progression or that it predicts future decline; it establishes association. Prospective studies that track PVT1 levels over years, alongside serial measurements of eGFR and albuminuria, will be needed to establish whether the molecule can forecast deterioration before conventional markers move.

There are also mechanistic questions that the clinical data raise but do not resolve. Is serum PVT1 merely a passive shed product of injured kidney cells, a molecular echo of tissue damage, or does it actively participate in the fibrotic and inflammatory processes that destroy glomeruli? Experimental evidence from cell and animal models suggests the latter is plausible, with PVT1 implicated in pathways of renal cell apoptosis and extracellular matrix accumulation under diabetic conditions. If the RNA is causally involved, it becomes not just a biomarker but a therapeutic target, and the authors of the new study explicitly frame it as such. Silencing or sequestering specific lncRNAs is technically feasible with antisense oligonucleotides and related technologies, several of which have already reached clinical use in other organ systems, though delivering such drugs safely to kidney tissue in diabetes remains a distant goal.

For now, the practical significance lies in diagnostics. A blood-based RNA marker could be measured alongside routine chemistry, potentially catching kidney involvement earlier or stratifying risk more finely than urine albumin alone. It could also help resolve the vexing subgroup of diabetic patients whose kidney function declines without marked albuminuria, a pattern increasingly recognized as its own clinical entity. The Egyptian setting matters as well: populations differ in genetic background, environmental exposures, and healthcare access, and biomarkers validated in one population do not automatically transfer to another. By demonstrating the PVT1 signal in an Egyptian cohort, the study extends the geographic and ethnic reach of the evidence, though replication in independent cohorts within Egypt and beyond remains essential before any clinical deployment.

The broader lesson is about where medicine is looking for its next generation of tests. For decades, clinical chemistry has been dominated by proteins and metabolites, molecules whose abundance reflects the downstream consequences of disease. Noncoding RNAs occupy a different layer of the biological hierarchy, closer to the regulatory programs that orchestrate tissue response to injury. Their dysregulation can be specific to particular pathological pathways in ways that generic markers like creatinine are not. The Cairo study, with its demonstration that a single serum lncRNA rises with diabetic kidney disease severity and independently predicts proteinuria, offers a concrete example of that promise. It also illustrates the standard trajectory of biomarker science: an intriguing association in a well-characterized cohort, followed by the harder work of validation, mechanistic dissection, and prospective testing. If PVT1 survives that gauntlet, the dark matter of the genome may earn a permanent place in the nephrologist’s toolkit, and patients with diabetes may gain an earlier, clearer warning that their kidneys are under siege.

Subject of Research: Serum long noncoding RNA PVT1 as a biomarker of diabetic nephropathy severity in Egyptian patients with type 2 diabetes

Article Title: Serum long noncoding RNA human plasmacytoma variant translocation 1 (PVT1) expression levels in Egyptians type 2 diabetic patients and its correlation with severity of diabetic nephropathy

Article References: Tarabay, A., Shaker, O. G., ElSayed, N. M., Allam, D., Abdellatef, A., & Attia, M. (2026). Serum long noncoding RNA human plasmacytoma variant translocation 1 (PVT1) expression levels in Egyptians type 2 diabetic patients and its correlation with severity of diabetic nephropathy. BMC Endocrine Disorders, 26(1), Article 275. https://doi.org/10.1186/s12902-026-02449-x

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02449-x

Keywords: type 2 diabetes, diabetic kidney disease, diabetic nephropathy, long noncoding RNA, PVT1, biomarker, albuminuria, proteinuria, eGFR, real-time PCR, Egypt, Cairo University

The timing and the geography of this launch matter. The editors describe their belief as rooted in cumulative experience gained in a continent and a region they characterize as plagued by both natural and man-made disasters. North Africa, the Middle East, and the wider African continent have contended in recent decades with earthquakes, floods, conflicts, displacement crises, and public health emergencies that place enormous strain on health systems. In such settings, the editors argue, sharing field experience must go hand in hand with rigorous methodology, because anecdote without evidence rarely changes outcomes, and evidence locked behind paywalls rarely reaches the clinicians and officials working in low-resource or crisis-affected environments.

The problem the new journal identifies is a familiar one in global health research: a persistent disconnect between what is published and what is practiced. The founding editorial notes that on a global level, from sudden natural catastrophes to complex humanitarian emergencies, timely and reliable information has repeatedly proven critical, yet researchers, practitioners, and policymakers are often caught by surprise and struggle to access up-to-date findings precisely where the stakes are highest. Disaster-prone and crisis-affected regions frequently lack institutional subscriptions to major journals, meaning that the communities with the most direct experience of mass casualties, infrastructure collapse, and emergency response are often the least able to read the literature about them. The Journal of Emergency and Disaster Medicine is explicitly designed to fill that gap.

Open access sits at the center of that design. The editors state plainly that in many settings where emergencies strike, budgets are tight and institutional subscriptions may be out of reach, so all articles in the journal will be freely accessible to readers worldwide. They frame this as a matter of principle rather than mere convenience, holding that scientific progress and clinical excellence should serve humanity without restriction. The journal is published under a Creative Commons Attribution 4.0 International license, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, provided the original authors and source are credited and changes are indicated. For frontline workers in humanitarian operations, that licensing model means research can be downloaded, printed, translated, and circulated in the field without negotiating copyright barriers in the middle of a crisis.

The journal’s scope is broad by design, reflecting the reality that disaster medicine is not a narrow specialty but a systems-level discipline. The editors invite contributions spanning all dimensions of acute and disaster-related care, including prehospital and emergency department medicine, trauma systems, disaster risk reduction, mass casualty response, humanitarian health services, public health emergencies, and the use of technology and innovation in crisis contexts. That breadth mirrors the way disasters actually unfold: a single earthquake engages ambulance dispatch protocols, emergency department triage, surgical capacity, water and sanitation systems, disease surveillance, and long-term rehabilitation of survivors, all at once. A journal that addresses any one of those domains in isolation risks missing the interdependencies that determine how many people survive.

Notably, the editors are not limiting the journal to conventional research formats. Alongside original research, reviews, and policy analyses, they explicitly encourage field reports and case studies that reflect real-world challenges and innovations. This is a methodologically significant choice. Much of the practical knowledge in disaster response exists as institutional memory in the heads of emergency physicians, logisticians, and humanitarian coordinators, and it often evaporates when operations end. Formalizing a venue for such accounts, subject to the same editorial scrutiny as traditional papers, could help convert hard-won field experience into a reusable, citable body of knowledge. The editors emphasize that their focus is on work that not only advances theoretical knowledge but also produces actionable strategies for preparedness, response, and recovery.

Quality control will rest with an Editorial Board that the editors describe as a body of experts drawn from different corners of the world, a composition intended to position the publication as an efficient tool in the prevention and management of emergencies and disasters. Submitted manuscripts will be evaluated by independent reviewers for originality, methodological soundness, clarity, and relevance, the standard pillars of peer review. The journal’s publication workflow is designed to minimize the delay between acceptance and public availability: once a manuscript is accepted, it will be published online immediately after professional copyediting and typesetting. In a field where outbreak dynamics, aftershocks, and mass casualty events move faster than traditional publication cycles, that speed of dissemination is presented as a core feature rather than an afterthought.

The institutional provenance of the journal adds a distinctive dimension. Kasr Al-Ainy Faculty of Medicine, founded in the nineteenth century, is one of the oldest and largest medical schools in Africa and the Middle East, and Cairo University’s teaching hospital complex functions as a major referral center for Egypt. Its emergency departments absorb an enormous and varied caseload, from road traffic trauma to the aftermath of regional emergencies, giving the institution direct operational familiarity with the challenges the journal addresses. A publication anchored in a high-volume, resource-constrained health system, rather than in a wealthy institution insulated from such pressures, has the potential to set different priorities: questions about triage under scarcity, surge capacity, and supply chain resilience are not hypothetical there.

The launch also arrives amid growing international attention to health emergency preparedness. The COVID-19 pandemic, alongside repeated climate-linked disasters and ongoing conflicts, has exposed weaknesses in how evidence flows to decision-makers during crises, and global frameworks for disaster risk reduction have called for stronger science-to-policy linkages. A journal dedicated to converting evidence into actionable strategies speaks directly to that agenda, and its open-access model lowers the barrier for contributions from researchers in low- and middle-income countries, who are frequently underrepresented in high-impact emergency medicine literature.

The founding editorial closes with an invitation rather than a declaration of arrival. Kassem and Mourad write that they envision the Journal of Emergency and Disaster Medicine becoming a go-to reference for clinicians, researchers, humanitarian professionals, and policymakers committed to saving lives under difficult conditions, and they look forward to submissions, critiques, and shared experience as the venture begins. The editorial, published as Volume 1, article number 1 of the journal, is itself open access, and the first issue will reveal whether the publication can attract the rigorous field research and policy work its founders describe. What is already clear is the editorial wager behind it: that in emergencies and disasters, the distance between evidence and action is measured in lives, and that shortening that distance begins with making the evidence universally available.

Subject of Research: The launch of an open-access journal on emergency and disaster medicine

Article Title: From evidence to action: The launch of the Journal of Emergency and Disaster Medicine by Kasr Al-Ainy Faculty of Medicine, Cairo University

Article References: From evidence to action: The launch of the Journal of Emergency and Disaster Medicine by Kasr Al-Ainy Faculty of Medicine, Cairo University. (n.d.). https://doi.org/10.1007/s44467-025-00005-6

Image Credits: AI Generated

DOI: 10.1007/s44467-025-00005-6

Keywords: emergency medicine, disaster medicine, open access, Cairo University, Kasr Al-Ainy, mass casualty response, humanitarian health, public health emergencies, trauma systems, disaster risk reduction, editorial, Springer Nature